NHSE915 Leasowe Medical Practice Alternative Provider Medical Services, including Special Allocation Scheme

Concepts

• warrington
• general practitioner
• leasowe medical practice alternative provider medical services
• nhse915 leasowe medical practice alternative provider medical services
• special allocation scheme
• the health care services
• the health care services (provider selection regime) regulations
• special
• medical
• leasowe

Location

Warrington

Description

This is an INTENTION TO AWARD Notice following The Health Care Services (Provider Selection Regime) Regulations 2023 - Competitive Process. North of England Commissioning Support (NECS) is a commissioning support service working for and on behalf of NHS Cheshire and Merseyside ICB (the Relevant Authority) who have undertaken a competition process to provide Leasowe Medical Practice Alternative Provider Medical Services, including Special Allocation Scheme. Contract Start Date: 01 April 2026 Contract End Date: 31 March 2036 The contract term is for an initial period of 4 years, with an option to extend for a further 3 years, plus the option to extend for an additional 3 years, at the discretion of the Relevant Authority and subject to satisfactory contractual and financial performance.

CPV Codes

• 85121100 - General-practitioner services

Other Information

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has now been formally awarded using the PSR Competitive Process. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Regulations 2024 (Procurement Act 2023) and/ or Public Contracts Regulations 2015 do not apply to this award. Contract Award Date: 29 August 2025 … Contract End Date: 31st March 2036 … The estimated revenue for Year 1 is £339,549 per annum, and £337,048 per annum for Years 2-10 of the contract. The total revenues for the full 10 year contract term are £3,372,990. There were no declared or potential conflicts of interest of individuals making the award decision.